For research use only. Not for therapeutic Use.
3′-Anhydro Ezetimibe(CAT: C000440) likely represents a metabolite or intermediate of Ezetimibe, a medication used to lower cholesterol levels in treating hyperlipidemia. Ezetimibe functions by inhibiting cholesterol absorption from the small intestine. In the pharmaceutical field, it plays a pivotal role in reducing LDL cholesterol levels, and mitigating the risk of cardiovascular disease.
| Catalog Number | C000440 |
| CAS Number | 204589-68-4 |
| Synonyms | (3R,4S)-1-(4-Fluorophenyl)-3-[(2E)-3-(4-fluorophenyl)-2-propen-1-yl]-4-(4-hydroxyphenyl)-2-azetidinone; [3R-[3α(E),4β]]-1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-2-propenyl]-4-(4-hydroxyphenyl)-2-azetidinone |
| Molecular Formula | C₂₄H₁₉F₂NO₂ |
| Purity | ≥95% |
| Solubility | Chloroform (Slightly, Sonicated), DMSO (Slightly), Methanol (Slightly, Sonicated |
| Appearance | Pale Yellow to Light Beige Solid |
| Storage | -20°C, Light sensitive, Light sensitive |
| Reference | van Heek, M., at al.: J. Pharmacol. Exp. Ther., 283, 157 (1997); van Heek, M., at al.: Brit. J. Pharmacol., 129, 1748 (2000); Irfan, A., et al.: Biotechnol. Biotechnol. Equip., 28, 5 (2014) |
